Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)

Status unconfirmed · Phase 2

Conditions studied: Preterm Premature Rupture of Membranes

In brief

The purpose of this study is to determine if the short term use of indomethacin will reduce the number of women delivering within 48 hours when given to women with preterm premature rupture of membranes (PPROM) between 24- 32 weeks of gestation. We hypothesize that indomethacin's anti-inflammatory and tocolytic action will reduce the number of women delivering within 48 hours when given to women with PPROM between 24-32 weeks of gestation.

Key facts

Study ID
NCT00466128
Run by
Thomas Jefferson University
People needed
116
Starts
2007-04-01
Expected to finish
2016-04-01
Last updated by the study team
2015-03-18

Who can join

Age: 15 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.